Gamco Investors INC. ET AL Purchases 4,900 Shares of Integer Holdings Corp (NYSE:ITGR)

Gamco Investors INC. ET AL lifted its position in Integer Holdings Corp (NYSE:ITGR) by 18.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,131 shares of the medical equipment provider’s stock after buying an additional 4,900 shares during the quarter. Gamco Investors INC. ET AL owned about 0.10% of Integer worth $2,428,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. grew its stake in shares of Integer by 66.3% in the third quarter. Russell Investments Group Ltd. now owns 90,310 shares of the medical equipment provider’s stock valued at $6,811,000 after buying an additional 35,994 shares in the last quarter. Palouse Capital Management Inc. grew its stake in shares of Integer by 32.5% in the third quarter. Palouse Capital Management Inc. now owns 3,834 shares of the medical equipment provider’s stock valued at $290,000 after buying an additional 941 shares in the last quarter. Sciencast Management LP bought a new position in shares of Integer in the third quarter valued at $204,000. Texas Permanent School Fund grew its stake in shares of Integer by 9.1% in the third quarter. Texas Permanent School Fund now owns 22,220 shares of the medical equipment provider’s stock valued at $1,679,000 after buying an additional 1,852 shares in the last quarter. Finally, Comerica Bank grew its stake in shares of Integer by 6.4% in the third quarter. Comerica Bank now owns 42,108 shares of the medical equipment provider’s stock valued at $3,198,000 after buying an additional 2,532 shares in the last quarter. 98.57% of the stock is owned by institutional investors and hedge funds.

In other Integer news, Director Pamela G. Bailey sold 7,446 shares of Integer stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $76.75, for a total transaction of $571,480.50. Following the completion of the transaction, the director now directly owns 56,990 shares of the company’s stock, valued at $4,373,982.50. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 2.24% of the company’s stock.

ITGR stock traded up $0.56 during midday trading on Friday, reaching $74.12. 207,312 shares of the company were exchanged, compared to its average volume of 220,155. The company has a debt-to-equity ratio of 0.73, a current ratio of 2.40 and a quick ratio of 1.35. The business has a 50-day moving average price of $75.55 and a two-hundred day moving average price of $76.73. Integer Holdings Corp has a one year low of $67.72 and a one year high of $92.61. The firm has a market capitalization of $2.51 billion, a price-to-earnings ratio of 19.51 and a beta of 1.02.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, October 31st. The medical equipment provider reported $1.20 EPS for the quarter, topping the Zacks’ consensus estimate of $1.06 by $0.14. Integer had a net margin of 8.99% and a return on equity of 13.47%. The firm had revenue of $303.59 million during the quarter, compared to analysts’ expectations of $313.78 million. During the same period in the previous year, the business posted $1.06 earnings per share. The company’s revenue for the quarter was down .5% compared to the same quarter last year. As a group, analysts anticipate that Integer Holdings Corp will post 4.62 earnings per share for the current fiscal year.

A number of equities analysts have commented on ITGR shares. Northcoast Research reaffirmed a “buy” rating on shares of Integer in a research report on Friday, August 2nd. ValuEngine cut shares of Integer from a “hold” rating to a “sell” rating in a research report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $65.76.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Featured Story: NASDAQ

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit